Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
作者： BOB DJAVAN , VINCENT RAVERY , ALEX ZLOTTA , PIOTR DOBRONSKI , MICHAEL DOBROVITS
DOI: 10.1016/S0022-5347(05)65652-2
关键词: Prostate biopsy 、 Prospective cohort study 、 Biopsy 、 Prostate cancer 、 Prostatectomy 、 Surgery 、 Urology 、 Prostate-specific antigen 、 Medicine 、 Prostate 、 Cancer
摘要: Purpose: We evaluated biochemical parameters and pathological features, as well biopsy related morbidity of prostate cancer detected on biopsies 2, 3 4 in men with total serum specific antigen (PSA) between 10 ng./ml. These features were compared to those 1.Materials Methods: In this prospective European Prostate Cancer Detection study 1,051 PSA underwent transrectal ultrasound guided sextant 2 additional transition zone biopsies. All patients whom samples negative for after 6 weeks. If also negative, even performed at 8-week intervals. Those clinically localized radical prostatectomy. Pathological clinical diagnosed either 1 or organ confined disease who agreed undergo prostatectomy compared.Results: detection rate...
jurology.com 参考文章(26)
Djavan B, Marberger M, Bursa B, Simak R, Basharkhah A, Susani M, Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Techniques in urology. ,vol. 5, pp. 139- ,(1999)
Bob Djavan, Michael Johann Marberger, Alexandre A.R. Zlolta, Claude Schulman, Thierry Roumeguere, Transition zone volume on transrectal ultrasonography is more accurate and reproducible than the total prostate volume BJUI. ,vol. 80, pp. 236- ,(1997)
David W. Keetch, William J. Catalona, Deborah S. Smith, Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values The Journal of Urology. ,vol. 151, pp. 1571- 1574 ,(1994) , 10.1016/S0022-5347(17)35304-1
G.C. Durkan, D.R. Greene, Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? BJUI. ,vol. 83, pp. 34- 38 ,(2008) , 10.1046/J.1464-410X.1999.00864.X
Thomas A. Stamey, Biological determinants of cancer progression in men with prostate cancer. JAMA. ,vol. 281, pp. 1395- 1400 ,(1999) , 10.1001/JAMA.281.15.1395
Ted O. Morgan, David G. McLeod, Eric S. Leifer, Gerald P. Murphy, Judd W. Moul, Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen Urology. ,vol. 48, pp. 76- 80 ,(1996) , 10.1016/S0090-4295(96)00615-2
Masanori Noguchi, Junro Yahara, Hiroshi Koga, Osamu Nakashima, Shinshi Noda, Necessity of repeat biopsies in men for suspected prostate cancer International Journal of Urology. ,vol. 6, pp. 7- 12 ,(1999) , 10.1046/J.1442-2042.1999.00611.X
W. Horninger, A. Reissigl, H. Klocker, H. Rogatsch, K. Fink, H. Strasser, G. Bartsch, Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels. The Prostate. ,vol. 37, pp. 133- 137 ,(1998) , 10.1002/(SICI)1097-0045(19981101)37:3<133::AID-PROS1>3.0.CO;2-W
David W. Keetch, William J. Catalona, Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. The Journal of Urology. ,vol. 154, pp. 1795- 1797 ,(1995) , 10.1016/S0022-5347(01)66786-7
William J. Catalona, Julia A. Beiser, Deborah S. Smith, SERUM FREE PROSTATE SPECIFIC ANTIGEN AND PROSTATE SPECIFIC ANTIGEN DENSITY MEASUREMENTS FOR PREDICTING CANCER IN MEN WITH PRIOR NEGATIVE PROSTATIC BIOPSIES The Journal of Urology. ,vol. 158, pp. 2162- 2167 ,(1997) , 10.1016/S0022-5347(01)68187-4